Skip to main content
NCBI home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1997;76(7):968–974. doi: 10.1038/bjc.1997.493

Effect of hepatitis C and B virus infection on risk of hepatocellular carcinoma: a prospective study.

J F Tsai 1, J E Jeng 1, M S Ho 1, W Y Chang 1, M Y Hsieh 1, Z Y Lin 1, J H Tsai 1
PMCID: PMC2228256  PMID: 9328161

Abstract

To assess whether there is an additive effect between chronic hepatitis B virus (HBV) and hepatitis C virus (HCV) infection on the development of hepatocellular carcinoma (HCC), 400 consecutive cirrhotic patients were followed prospectively with periodic abdominal ultrasound examination and measurement of serum alpha-fetoprotein (AFP) level every 4 months. During a follow-up of 1185 person-years, 80 (20%) patients developed HCC, with an annual incidence of 6.8%. The annual incidence was 2.0% in patients negative for hepatitis B surface antigen (HBsAg) and antibodies to HCV (anti-HCV), 6.6% in patients with HBsAg alone, 7.0% in patients with anti-HCV alone and 13.3% in patients co-infected with HBV and HCV. There was a positive linear trend in the annual incidence of HCC among patients without either marker, patients with single viral infection and patients with dual viral infection (P[for trend] < 0.0001). Cox's proportional hazard model indicated that HCV/HBV co-infection [hazard ratio (HR), 6.41; 95% confidence interval (CI), 1.80-22.80], anti-HCV alone (HR, 3.74; 95% CI, 1.07-13.07) and HBsAg alone (HR, 4.06; 95% CI, 1.23-13.34) were independently risk factors of HCC. In conclusion, there is an additive and independent effect modification of HCV and HBV infection on HCC development.

Full text

PDF
968

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Alberti A., Pontisso P., Chemello L., Fattovich G., Benvegnù L., Belussi F., De Mitri M. S. The interaction between hepatitis B virus and hepatitis C virus in acute and chronic liver disease. J Hepatol. 1995;22(1 Suppl):38–41. [PubMed] [Google Scholar]
  2. Benvegnù L., Fattovich G., Noventa F., Tremolada F., Chemello L., Cecchetto A., Alberti A. Concurrent hepatitis B and C virus infection and risk of hepatocellular carcinoma in cirrhosis. A prospective study. Cancer. 1994 Nov 1;74(9):2442–2448. doi: 10.1002/1097-0142(19941101)74:9<2442::aid-cncr2820740909>3.0.co;2-#. [DOI] [PubMed] [Google Scholar]
  3. Chen D. S. Natural history of chronic hepatitis B virus infection: new light on an old story. J Gastroenterol Hepatol. 1993 Sep-Oct;8(5):470–475. doi: 10.1111/j.1440-1746.1993.tb01551.x. [DOI] [PubMed] [Google Scholar]
  4. Collazos J., Genolla J., Ruibal A. Preliminary study of alpha-fetoprotein in nonmalignant liver diseases. A clinico-biochemical evaluation. Int J Biol Markers. 1992 Apr-Jun;7(2):97–102. doi: 10.1177/172460089200700205. [DOI] [PubMed] [Google Scholar]
  5. Curley S. A., Izzo F., Gallipoli A., de Bellis M., Cremona F., Parisi V. Identification and screening of 416 patients with chronic hepatitis at high risk to develop hepatocellular cancer. Ann Surg. 1995 Sep;222(3):375–383. doi: 10.1097/00000658-199509000-00014. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Diamantis I. D., McGandy C. E., Chen T. J., Liaw Y. F., Gudat F., Bianchi L. Detection of hepatitis B and C viruses in liver tissue with hepatocellular carcinoma. J Hepatol. 1994 Mar;20(3):405–409. doi: 10.1016/s0168-8278(94)80016-2. [DOI] [PubMed] [Google Scholar]
  7. Ikeda K., Saitoh S., Koida I., Arase Y., Tsubota A., Chayama K., Kumada H., Kawanishi M. A multivariate analysis of risk factors for hepatocellular carcinogenesis: a prospective observation of 795 patients with viral and alcoholic cirrhosis. Hepatology. 1993 Jul;18(1):47–53. [PubMed] [Google Scholar]
  8. Jeng J. E., Tsai J. F. Hepatitis C virus antibody in hepatocellular carcinoma in Taiwan. J Med Virol. 1991 May;34(1):74–77. doi: 10.1002/jmv.1890340113. [DOI] [PubMed] [Google Scholar]
  9. Kaklamani E., Trichopoulos D., Tzonou A., Zavitsanos X., Koumantaki Y., Hatzakis A., Hsieh C. C., Hatziyannis S. Hepatitis B and C viruses and their interaction in the origin of hepatocellular carcinoma. JAMA. 1991 Apr 17;265(15):1974–1976. [PubMed] [Google Scholar]
  10. Kiyosawa K., Sodeyama T., Tanaka E., Gibo Y., Yoshizawa K., Nakano Y., Furuta S., Akahane Y., Nishioka K., Purcell R. H. Interrelationship of blood transfusion, non-A, non-B hepatitis and hepatocellular carcinoma: analysis by detection of antibody to hepatitis C virus. Hepatology. 1990 Oct;12(4 Pt 1):671–675. doi: 10.1002/hep.1840120409. [DOI] [PubMed] [Google Scholar]
  11. Paterlini P., Driss F., Nalpas B., Pisi E., Franco D., Berthelot P., Bréchot C. Persistence of hepatitis B and hepatitis C viral genomes in primary liver cancers from HBsAg-negative patients: a study of a low-endemic area. Hepatology. 1993 Jan;17(1):20–29. [PubMed] [Google Scholar]
  12. Peto R., Pike M. C., Armitage P., Breslow N. E., Cox D. R., Howard S. V., Mantel N., McPherson K., Peto J., Smith P. G. Design and analysis of randomized clinical trials requiring prolonged observation of each patient. I. Introduction and design. Br J Cancer. 1976 Dec;34(6):585–612. doi: 10.1038/bjc.1976.220. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Popper H. Viral versus chemical hepatocarcinogenesis. J Hepatol. 1988 Apr;6(2):229–238. doi: 10.1016/s0168-8278(88)80037-0. [DOI] [PubMed] [Google Scholar]
  14. Pugh R. N., Murray-Lyon I. M., Dawson J. L., Pietroni M. C., Williams R. Transection of the oesophagus for bleeding oesophageal varices. Br J Surg. 1973 Aug;60(8):646–649. doi: 10.1002/bjs.1800600817. [DOI] [PubMed] [Google Scholar]
  15. Simonetti R. G., Cammà C., Fiorello F., Cottone M., Rapicetta M., Marino L., Fiorentino G., Craxì A., Ciccaglione A., Giuseppetti R. Hepatitis C virus infection as a risk factor for hepatocellular carcinoma in patients with cirrhosis. A case-control study. Ann Intern Med. 1992 Jan 15;116(2):97–102. doi: 10.7326/0003-4819-116-2-97. [DOI] [PubMed] [Google Scholar]
  16. Simonetti R. G., Cammà C., Fiorello F., Politi F., D'Amico G., Pagliaro L. Hepatocellular carcinoma. A worldwide problem and the major risk factors. Dig Dis Sci. 1991 Jul;36(7):962–972. doi: 10.1007/BF01297149. [DOI] [PubMed] [Google Scholar]
  17. Takano S., Yokosuka O., Imazeki F., Tagawa M., Omata M. Incidence of hepatocellular carcinoma in chronic hepatitis B and C: a prospective study of 251 patients. Hepatology. 1995 Mar;21(3):650–655. [PubMed] [Google Scholar]
  18. Tong M. J., el-Farra N. S., Reikes A. R., Co R. L. Clinical outcomes after transfusion-associated hepatitis C. N Engl J Med. 1995 Jun 1;332(22):1463–1466. doi: 10.1056/NEJM199506013322202. [DOI] [PubMed] [Google Scholar]
  19. Tsai J. F., Chang W. Y., Jeng J. E., Ho M. S., Lin Z. Y., Tsai J. H. Effects of hepatitis C and B viruses infection on the development of hepatocellular carcinoma. J Med Virol. 1994 Sep;44(1):92–95. doi: 10.1002/jmv.1890440117. [DOI] [PubMed] [Google Scholar]
  20. Tsai J. F., Chang W. Y., Jeng J. E., Ho M. S., Lin Z. Y., Tsai J. H. Frequency of raised alpha-fetoprotein level among Chinese patients with hepatocellular carcinoma related to hepatitis B and C. Br J Cancer. 1994 Jun;69(6):1157–1159. doi: 10.1038/bjc.1994.227. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Tsai J. F., Chang W. Y., Jeng J. E., Ho M. S., Lin Z. Y., Tsai J. H. Hepatitis B and C virus infection as risk factors for liver cirrhosis and cirrhotic hepatocellular carcinoma: a case-control study. Liver. 1994 Apr;14(2):98–102. doi: 10.1111/j.1600-0676.1994.tb00055.x. [DOI] [PubMed] [Google Scholar]
  22. Tsai J. F., Chang W. Y., Jeng J. E., Ho M. S., Wang L. Y., Hsieh M. Y., Chen S. C., Chuang W. L., Lin Z. Y., Tsai J. H. Hepatitis C virus infection as a risk factor for non-alcoholic liver cirrhosis in Taiwan. J Med Virol. 1993 Dec;41(4):296–300. doi: 10.1002/jmv.1890410407. [DOI] [PubMed] [Google Scholar]
  23. Tsai J. F., Jeng J. E., Chang W. Y., Ho M. S., Lin Z. Y., Tsai J. H. Increased IgM-containing circulating immune complexes in patients co-infected with hepatitis C and hepatitis B. Medicine (Baltimore) 1995 May;74(3):136–143. doi: 10.1097/00005792-199505000-00003. [DOI] [PubMed] [Google Scholar]
  24. Tsai J. F., Jeng J. E., Ho M. S., Chang W. Y., Hsieh M. Y., Lin Z. Y., Tsai J. H. Additive effect modification of hepatitis B surface antigen and e antigen on the development of hepatocellular carcinoma. Br J Cancer. 1996 Jun;73(12):1498–1502. doi: 10.1038/bjc.1996.283. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Tsai J. F., Jeng J. E., Ho M. S., Chang W. Y., Lin Z. Y., Tsai J. H. Independent and additive effect modification of hepatitis C and B viruses infection on the development of chronic hepatitis. J Hepatol. 1996 Mar;24(3):271–276. doi: 10.1016/s0168-8278(96)80004-3. [DOI] [PubMed] [Google Scholar]
  26. Tsai J. F., Jeng J. E., Ho M. S., Wang C. S., Chang W. Y., Hsieh M. Y., Lin Z. Y., Tsai J. H. Serum alanine aminotransferase level in relation to hepatitis B and C virus infections among blood donors. Liver. 1997 Feb;17(1):24–29. doi: 10.1111/j.1600-0676.1997.tb00774.x. [DOI] [PubMed] [Google Scholar]
  27. Tsai J. F., Margolis H. S., Jeng J. E., Ho M. S., Chang W. Y., Lin Z. Y., Tsai J. H. Circulating immune complexes in chronic hepatitis related to hepatitis C and B viruses infection. Clin Immunol Immunopathol. 1995 Apr;75(1):39–44. doi: 10.1006/clin.1995.1050. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES